Artículos de revistas sobre el tema "DYRK2"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "DYRK2".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Correa-Sáez, Alejandro, Rafael Jiménez-Izquierdo, Martín Garrido-Rodríguez, Rosario Morrugares, Eduardo Muñoz y Marco A. Calzado. "Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases". Cellular and Molecular Life Sciences 77, n.º 23 (27 de mayo de 2020): 4747–63. http://dx.doi.org/10.1007/s00018-020-03556-1.
Texto completoKinstrie, Ross, Pamela A. Lochhead, Gary Sibbet, Nick Morrice y Vaughn Cleghon. "dDYRK2 and Minibrain interact with the chromatin remodelling factors SNR1 and TRX". Biochemical Journal 398, n.º 1 (27 de julio de 2006): 45–54. http://dx.doi.org/10.1042/bj20060159.
Texto completoBanerjee, Sourav, Chenggong Ji, Joshua E. Mayfield, Apollina Goel, Junyu Xiao, Jack E. Dixon y Xing Guo. "Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2". Proceedings of the National Academy of Sciences 115, n.º 32 (9 de julio de 2018): 8155–60. http://dx.doi.org/10.1073/pnas.1806797115.
Texto completoSeo, D. H., H. W. Ma, S. Kim, D. H. Kim, H. K. Kim, S. H. Lee, S. Kim et al. "P001 The novel DYRK1a inhibitor VRN024219 alleviates disease severity on the IBD mouse models by modulating T-cell differentiation". Journal of Crohn's and Colitis 14, Supplement_1 (enero de 2020): S129. http://dx.doi.org/10.1093/ecco-jcc/jjz203.130.
Texto completoBanerjee, Sourav, Tiantian Wei, Jue Wang, Jenna J. Lee, Haydee L. Gutierrez, Owen Chapman, Sandra E. Wiley et al. "Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression". Proceedings of the National Academy of Sciences 116, n.º 49 (21 de noviembre de 2019): 24881–91. http://dx.doi.org/10.1073/pnas.1912033116.
Texto completoPark, Chun Shik, Ye Shen, Koramit Suppipat, Andrew Lewis, Julie Tomolonis, Monica Puppi, toni-Ann Mistretta, Leyuan Ma, Michael R. Green y Daniel Lacorazza. "DYRK2 Inhibits the Self-Renewal of Leukemic Stem Cells in Chronic Myeloid Leukemia By Inducing Degradation of c-Myc Downstream of the Reprogramming Factor KLF4". Blood 128, n.º 22 (2 de diciembre de 2016): 1879. http://dx.doi.org/10.1182/blood.v128.22.1879.1879.
Texto completoMao, Cui, Xing Ju, Haijian Cheng, Xixia Huang, Fugui Jiang, Yuni Yao, Xianyong Lan y Enliang Song. "Determination of genetic variation within the <i>DYRK2</i> gene and its associations with milk traits in cattle". Archives Animal Breeding 63, n.º 2 (9 de septiembre de 2020): 315–23. http://dx.doi.org/10.5194/aab-63-315-2020.
Texto completoMorrugares, Rosario, Alejandro Correa-Sáez, Rita Moreno, Martín Garrido-Rodríguez, Eduardo Muñoz, Laureano de la Vega y Marco A. Calzado. "Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2". Cellular and Molecular Life Sciences 77, n.º 13 (11 de octubre de 2019): 2621–39. http://dx.doi.org/10.1007/s00018-019-03309-9.
Texto completoShen, Yifen, Li Zhang, Donglin Wang, Yifeng Bao, Chao Liu, Zhiwei Xu, Wei Huang y Chun Cheng. "Regulation of Glioma Cells Migration by DYRK2". Neurochemical Research 42, n.º 11 (4 de julio de 2017): 3093–102. http://dx.doi.org/10.1007/s11064-017-2345-2.
Texto completoAman, La Ode, Rahmana Emran Kartasasmita y Daryono Hadi Tjahjono. "Virtual screening of curcumin analogues as DYRK2 inhibitor: Pharmacophore analysis, molecular docking and dynamics, and ADME prediction". F1000Research 10 (17 de mayo de 2021): 394. http://dx.doi.org/10.12688/f1000research.28040.1.
Texto completoOng, Su Sien, Asli N. Goktug, Ayesha Elias, Jing Wu, Darren Saunders y Taosheng Chen. "Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine/threonine kinase DYRK2". Biochemical Journal 459, n.º 1 (14 de marzo de 2014): 193–203. http://dx.doi.org/10.1042/bj20130558.
Texto completoErickson-Miller, Connie L., Caretha Creasy, Antony Chadderton, Christopher B. Hopson, Elizabeth I. Valoret, Michele Gorczyca, Louis Elefante et al. "GSK626616: A DYRK3 Inhibitor as a Potential New Therapy for the Treatment of Anemia." Blood 110, n.º 11 (16 de noviembre de 2007): 510. http://dx.doi.org/10.1182/blood.v110.11.510.510.
Texto completoPark, Chun Shik y H. Daniel Lacorazza. "DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells". Experimental & Molecular Medicine 52, n.º 10 (octubre de 2020): 1663–72. http://dx.doi.org/10.1038/s12276-020-00515-5.
Texto completoSun, Yuxiang, Xin Ge, Mengmeng Li, Li Xu y Yaodong Shen. "Dyrk2 involved in regulating LPS-induced neuronal apoptosis". International Journal of Biological Macromolecules 104 (noviembre de 2017): 979–86. http://dx.doi.org/10.1016/j.ijbiomac.2017.06.087.
Texto completoPark, Chun Shik, Andrew H. Lewis, Taylor J. Chen, Cory S. Bridges, Ye Shen, Koramit Suppipat, Monica Puppi et al. "A KLF4-DYRK2–mediated pathway regulating self-renewal in CML stem cells". Blood 134, n.º 22 (28 de noviembre de 2019): 1960–72. http://dx.doi.org/10.1182/blood.2018875922.
Texto completoWOODS, Yvonne L., Philip COHEN, Walter BECKER, Ross JAKES, Michel GOEDERT, Xuemin WANG y Christopher G. PROUD. "The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bɛ at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase". Biochemical Journal 355, n.º 3 (24 de abril de 2001): 609–15. http://dx.doi.org/10.1042/bj3550609.
Texto completoLi, Xu, Min Wang, Jian-Xin Jiang, Rui Tian, Cheng-Jian Shi y Ren-Yi Qin. "Clinical significance of expression of DYRK2 in pancreatic cancer". World Chinese Journal of Digestology 21, n.º 15 (2013): 1442. http://dx.doi.org/10.11569/wcjd.v21.i15.1442.
Texto completoNihira, Naoe Taira y Kiyotsugu Yoshida. "Engagement of DYRK2 in proper control for cell division". Cell Cycle 14, n.º 6 (19 de marzo de 2015): 802–7. http://dx.doi.org/10.1080/15384101.2015.1007751.
Texto completoYoshida, Saishu y Kiyotsugu Yoshida. "Multiple functions of DYRK2 in cancer and tissue development". FEBS Letters 593, n.º 21 (18 de septiembre de 2019): 2953–65. http://dx.doi.org/10.1002/1873-3468.13601.
Texto completoLaham, Amina Jamal, Raafat El-Awady, Jean-Jacques Lebrun y Maha Saber Ayad. "A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer". Cancers 14, n.º 8 (18 de abril de 2022): 2034. http://dx.doi.org/10.3390/cancers14082034.
Texto completoKarpov, Pavel, Aleksey Raevsky, Maxim Korablyov y Yaroslav Blume. "Identification of Plant Homologues of Dual Specificity Yak1-Related Kinases". Computational Biology Journal 2014 (8 de diciembre de 2014): 1–14. http://dx.doi.org/10.1155/2014/909268.
Texto completoHossain, Delowar, Jérémy A. Ferreira Barbosa, Éric A. Cohen y William Y. Tsang. "HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1to disrupt centrosome homeostasis". Journal of Biological Chemistry 293, n.º 24 (3 de mayo de 2018): 9448–60. http://dx.doi.org/10.1074/jbc.ra117.001444.
Texto completoSun, Wei, Shuang Jiao, Xungang Tan, Peijun Zhang y Feng You. "DYRK2 displays muscle fiber type specific function during zebrafish early somitogenesis". International Journal of Developmental Biology 61, n.º 6-7 (2017): 459–63. http://dx.doi.org/10.1387/ijdb.160175sj.
Texto completoLuebbering, Nathan, Mark Charlton-Perkins, Justin P. Kumar, Stephanie M. Rollmann, Tiffany Cook y Vaughn Cleghon. "Drosophila Dyrk2 Plays a Role in the Development of the Visual System". PLoS ONE 8, n.º 10 (11 de octubre de 2013): e76775. http://dx.doi.org/10.1371/journal.pone.0076775.
Texto completoBahl, Anu, Prashant Joshi, Sandip B. Bharate y Harish Chopra. "Pharmacophore modeling and 3D-QSAR studies of leucettines as potent Dyrk2 inhibitors". Medicinal Chemistry Research 23, n.º 4 (26 de septiembre de 2013): 1925–33. http://dx.doi.org/10.1007/s00044-013-0767-1.
Texto completoMimoto, Rei, Naoe Taira, Hiroyuki Takahashi, Tomoko Yamaguchi, Masataka Okabe, Ken Uchida, Yoshio Miki y Kiyotsugu Yoshida. "DYRK2 controls the epithelial–mesenchymal transition in breast cancer by degrading Snail". Cancer Letters 339, n.º 2 (octubre de 2013): 214–25. http://dx.doi.org/10.1016/j.canlet.2013.06.005.
Texto completoJung, Hae-Yun, Xin Wang, Sohee Jun y Jae-Il Park. "Dyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation". Journal of Biological Chemistry 288, n.º 10 (28 de enero de 2013): 7252–62. http://dx.doi.org/10.1074/jbc.m112.416792.
Texto completoPérez, Moisés, Carmen García-Limones, Inés Zapico, Anabel Marina, M. Lienhard Schmitz, Eduardo Muñoz y Marco A. Calzado. "Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways". Journal of Molecular Cell Biology 4, n.º 5 (9 de agosto de 2012): 316–30. http://dx.doi.org/10.1093/jmcb/mjs047.
Texto completoXu, Li, Yuxiang Sun, Mengmeng Li y Xin Ge. "Dyrk2 mediated the release of proinflammatory cytokines in LPS-induced BV2 cells". International Journal of Biological Macromolecules 109 (abril de 2018): 1115–24. http://dx.doi.org/10.1016/j.ijbiomac.2017.11.095.
Texto completoVerPlank, Jordan J. S. y Alfred L. Goldberg. "Regulating protein breakdown through proteasome phosphorylation". Biochemical Journal 474, n.º 19 (25 de septiembre de 2017): 3355–71. http://dx.doi.org/10.1042/bcj20160809.
Texto completoMaddika, Subbareddy y Junjie Chen. "Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase". Nature Cell Biology 11, n.º 4 (15 de marzo de 2009): 409–19. http://dx.doi.org/10.1038/ncb1848.
Texto completoCuny, Gregory D., Maxime Robin, Natalia P. Ulyanova, Debasis Patnaik, Valerie Pique, Gilles Casano, Ji-Feng Liu et al. "Structure–activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors". Bioorganic & Medicinal Chemistry Letters 20, n.º 12 (junio de 2010): 3491–94. http://dx.doi.org/10.1016/j.bmcl.2010.04.150.
Texto completoMimoto, R., Y. Imawari, S. Hirooka, H. Takeyama y K. Yoshida. "Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer". Oncogene 36, n.º 13 (10 de octubre de 2016): 1862–72. http://dx.doi.org/10.1038/onc.2016.349.
Texto completoAn, Tai, Shu Li, Wei Pan, Po Tien, Bo Zhong, Hong-Bing Shu y Shuwen Wu. "DYRK2 Negatively Regulates Type I Interferon Induction by Promoting TBK1 Degradation via Ser527 Phosphorylation". PLOS Pathogens 11, n.º 9 (25 de septiembre de 2015): e1005179. http://dx.doi.org/10.1371/journal.ppat.1005179.
Texto completoWeiss, Celine S., Marco M. Ochs, Marco Hagenmueller, Marcus R. Streit, Pratima Malekar, Johannes H. Riffel, Sebastian J. Buss et al. "DYRK2 Negatively Regulates Cardiomyocyte Growth by Mediating Repressor Function of GSK-3β on eIF2Bε". PLoS ONE 8, n.º 9 (4 de septiembre de 2013): e70848. http://dx.doi.org/10.1371/journal.pone.0070848.
Texto completoEnomoto, Yasuko, Shin-ichi Yamashita, Yasuteru Yoshinaga, Yasuyoshi Fukami, So Miyahara, Kazuki Nabeshima y Akinori Iwasaki. "Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer". Tumor Biology 35, n.º 11 (6 de agosto de 2014): 11021–25. http://dx.doi.org/10.1007/s13277-014-2413-z.
Texto completoZhang, Xiubing, Pan Xu, Wenkai Ni, Hui Fan, Jian Xu, Yongmei Chen, Wei Huang et al. "Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma". Pathology - Research and Practice 212, n.º 3 (marzo de 2016): 162–70. http://dx.doi.org/10.1016/j.prp.2016.01.002.
Texto completoYamaguchi, Noriko, Rei Mimoto, Nozomu Yanaihara, Yoshimi Imawari, Shinichi Hirooka, Aikou Okamoto y Kiyotsugu Yoshida. "DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma". Tumor Biology 36, n.º 8 (25 de febrero de 2015): 5913–23. http://dx.doi.org/10.1007/s13277-015-3264-y.
Texto completoWang, Yuchan, Yaxun Wu, Xiaobing Miao, Xinghua Zhu, Xianjing Miao, Yunhua He, Fei Zhong et al. "Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma". International Journal of Biological Macromolecules 81 (noviembre de 2015): 809–17. http://dx.doi.org/10.1016/j.ijbiomac.2015.08.067.
Texto completoSun, Wei, Xungang Tan, Peijun Zhang, Yuqing Zhang y Yongli Xu. "Characterization of DYRK2 (dual-specificity tyrosine-phosphorylation-regulated kinase 2) from Zebrafish (Dario rerio)". Chinese Journal of Oceanology and Limnology 28, n.º 4 (29 de junio de 2010): 720–24. http://dx.doi.org/10.1007/s00343-010-9073-7.
Texto completoYokoyama-Mashima, Shiho, Satomi Yogosawa, Yumi Kanegae, Shinichi Hirooka, Saishu Yoshida, Takashi Horiuchi, Toya Ohashi et al. "Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer". Cancer Letters 451 (junio de 2019): 100–109. http://dx.doi.org/10.1016/j.canlet.2019.02.046.
Texto completoAuld, Gillian C., David G. Campbell, Nick Morrice y Philip Cohen. "Identification of calcium-regulated heat-stable protein of 24 kDa (CRHSP24) as a physiological substrate for PKB and RSK using KESTREL". Biochemical Journal 389, n.º 3 (26 de julio de 2005): 775–83. http://dx.doi.org/10.1042/bj20050733.
Texto completoBoni, Jacopo, Carlota Rubio-Perez, Nuria López-Bigas, Cristina Fillat y Susana de la Luna. "The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities". Cancers 12, n.º 8 (29 de julio de 2020): 2106. http://dx.doi.org/10.3390/cancers12082106.
Texto completoTaira, Naoe, Hiroyuki Yamamoto, Tomoko Yamaguchi, Yoshio Miki y Kiyotsugu Yoshida. "ATM Augments Nuclear Stabilization of DYRK2 by Inhibiting MDM2 in the Apoptotic Response to DNA Damage". Journal of Biological Chemistry 285, n.º 7 (4 de diciembre de 2009): 4909–19. http://dx.doi.org/10.1074/jbc.m109.042341.
Texto completoMimoto, Rei, Naoe T. Nihira, Shinichi Hirooka, Hiroshi Takeyama y Kiyotsugu Yoshida. "Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR". Cancer Letters 384 (enero de 2017): 27–38. http://dx.doi.org/10.1016/j.canlet.2016.10.015.
Texto completoTANAKA, MASUMI, SHIN-ICHI YAMASHITA, YASUTERU YOSHINAGA, YASUKO ENOMOTO, YUKI NOHARA, SYUKO ONO, KAZUKI NABESHIMA, AKINORI IWASAKI y TOSHIHIKO SATO. "Combination of DYRK2 and TERT Expression Is a Powerful Predictive Marker for Early-stage Breast Cancer Recurrence". Anticancer Research 42, n.º 4 (28 de marzo de 2022): 2079–85. http://dx.doi.org/10.21873/anticanres.15689.
Texto completoZhang, Xiaojing, Runze Xiao, Bing Lu, Han Wu, Chunyi Jiang, Peng Li y Jianfei Huang. "Kinase DYRK2 acts as a regulator of autophagy and an indicator of favorable prognosis in gastric carcinoma". Colloids and Surfaces B: Biointerfaces 209 (enero de 2022): 112182. http://dx.doi.org/10.1016/j.colsurfb.2021.112182.
Texto completoTaira, Naoe, Rei Mimoto, Morito Kurata, Tomoko Yamaguchi, Masanobu Kitagawa, Yoshio Miki y Kiyotsugu Yoshida. "DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells". Journal of Clinical Investigation 122, n.º 3 (1 de marzo de 2012): 859–72. http://dx.doi.org/10.1172/jci60818.
Texto completoRyu, Ki-Jun, Sun-Mi Park, Seung-Ho Park, In-Kyu Kim, Hyeontak Han, Hyo-Jin Kim, Seon-Hee Kim et al. "p38 Stabilizes Snail by Suppressing DYRK2-Mediated Phosphorylation That Is Required for GSK3β-βTrCP–Induced Snail Degradation". Cancer Research 79, n.º 16 (17 de junio de 2019): 4135–48. http://dx.doi.org/10.1158/0008-5472.can-19-0049.
Texto completoNishi, Y., E. Rogers, S. M. Robertson y R. Lin. "Polo kinases regulate C. elegans embryonic polarity via binding to DYRK2-primed MEX-5 and MEX-6". Development 135, n.º 4 (15 de febrero de 2008): 687–97. http://dx.doi.org/10.1242/dev.013425.
Texto completo